Healthcare provider profile · identity verified

Mark D Raizin, M.D.

Internal Medicine · PEABODY, MA · NPI 1699702290

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Simvastatin	Simvastatin	519	151
Atorvastatin Calcium	Atorvastatin Calcium	414	128
Lisinopril	Lisinopril	414	113
Amlodipine Besylate	Amlodipine Besylate	341	102
Levothyroxine Sodium	Levothyroxine Sodium	272	74
Metoprolol Succinate	Metoprolol Succinate	260	63
Omeprazole	Omeprazole	238	73
Hydrochlorothiazide	Hydrochlorothiazide	186	58
Lorazepam	Lorazepam	184	39
Gabapentin	Gabapentin	176	42
Tamsulosin Hcl	Tamsulosin Hcl	170	50
Testosterone Cypionate	Testosterone Cypionate	155	16
Citalopram Hbr	Citalopram Hydrobromide	150	37
Atenolol	Atenolol	141	40
Pantoprazole Sodium	Pantoprazole Sodium	140	39
Eliquis	Apixaban	136	28
Metformin Hcl	Metformin Hcl	108	29
Pravastatin Sodium	Pravastatin Sodium	94	31
Albuterol Sulfate Hfa	Albuterol Sulfate	93	37
Losartan Potassium	Losartan Potassium	89	27
Furosemide	Furosemide	85	24
Allopurinol	Allopurinol	80	19
Trazodone Hcl	Trazodone Hcl	80	25
Clonazepam	Clonazepam	78	17
Enalapril Maleate	Enalapril Maleate	76	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	12
Rosuvastatin Calcium	Rosuvastatin Calcium	68	23
Sertraline Hcl	Sertraline Hcl	68	22
Metoprolol Tartrate	Metoprolol Tartrate	63	24
Tramadol Hcl	Tramadol Hcl	61	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	58	suppressed
Finasteride	Finasteride	57	17
Fluticasone Propionate	Fluticasone Propionate	57	21
Metformin Hcl Er	Metformin Hcl	55	17
Mirtazapine	Mirtazapine	54	18
Fluoxetine Hcl	Fluoxetine Hcl	50	15
Xarelto	Rivaroxaban	49	11
Oxybutynin Chloride Er	Oxybutynin Chloride	47	15
Carvedilol	Carvedilol	46	12
Ozempic	Semaglutide	46	11
Alprazolam	Alprazolam	45	suppressed
Trulicity	Dulaglutide	45	suppressed
Duloxetine Hcl	Duloxetine Hcl	44	12
Doxepin Hcl	Doxepin Hcl	41	suppressed
Spironolactone	Spironolactone	39	12
Clopidogrel	Clopidogrel Bisulfate	38	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	38	suppressed
Donepezil Hcl	Donepezil Hcl	38	suppressed
Glipizide Er	Glipizide	38	suppressed
Alendronate Sodium	Alendronate Sodium	37	11
Jardiance	Empagliflozin	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Famotidine	Famotidine	34	suppressed
Arnuity Ellipta	Fluticasone Furoate	33	suppressed
Warfarin Sodium	Warfarin Sodium	32	11
Buspirone Hcl	Buspirone Hcl	31	suppressed
Glimepiride	Glimepiride	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	13
Glipizide	Glipizide	29	suppressed
Ipratropium Bromide	Ipratropium Bromide	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	11
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Prednisone	Prednisone	28	23
Oxazepam	Oxazepam	27	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Mometasone Furoate	Mometasone Furoate	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Diazepam	Diazepam	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Oxycontin	Oxycodone Hcl	20	suppressed
Amoxicillin	Amoxicillin	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	17
Aripiprazole	Aripiprazole	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	11
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ketoconazole	Ketoconazole	16	12
Labetalol Hcl	Labetalol Hcl	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Valsartan	Valsartan	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Estradiol	Estradiol	15	suppressed
Torsemide	Torsemide	15	suppressed
Imiquimod	Imiquimod	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	13
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Latanoprost	Latanoprost	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error